Discontinuation report HUMULIN R
| Report ID | 257304 |
| Drug Identification Number | 00586714 |
| Brand name | HUMULIN R |
| Common or Proper name | insulin, human biosynthetic |
| Company Name | ELI LILLY CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN SEMI SYNTHETIC HUMAN |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | Vial HI0210, 10 mL, 100 units/mL |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-04-30 |
| Actual discontinuation date | |
| Remaining supply date | 2026-04-30 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | The 10 mL vial presentation (Vial HI0210, 10 mL, 100 units/mL) is being discontinued, anticipated remaining supply date may be impacted based on any changes in demand. The following presentations remain available: Humulin R 3.0 mL, 100 units /mL, 5 cartridges/box HI0219 (DIN 01959220), Humulin R 3.0 mL prefilled pen, 100 units/mL, KwikPen HP8804 (DIN 02415089) |
| Company comments | For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-05-14 | French | Compare |
| v1 | 2025-05-14 | English | Compare |
Showing 1 to 2 of 2